ASSESSING THE LONGER-TERM EFFICACY OF BIOLOGIC THERAPIES AND APREMILAST FOR PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引:0
|
作者
Sawyer, L. [1 ]
Fotheringham, I [1 ]
Comic, L. [1 ]
Yasmeen, N. [1 ]
Jemec, G. [2 ]
Levin, L. [3 ]
Hansen, J. B. [4 ]
Gibbons, C. [4 ]
Moller, A. H. [4 ]
Marques, R. [5 ]
机构
[1] Symmetron Ltd, Elstree, England
[2] Roskilde Hosp, Roskilde, Denmark
[3] Linkoping Univ, Linkoping, Sweden
[4] LEO Pharma AS, Ballerup, Denmark
[5] LEO Farmaceut Lda, Lisbon, Portugal
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSS3
引用
收藏
页码:A801 / A801
页数:1
相关论文
共 50 条
  • [1] Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis
    Kyle Fahrbach
    Grammati Sarri
    David M. Phillippo
    Binod Neupane
    Samantha E. Martel
    Sandeep Kiri
    Kristian Reich
    [J]. Dermatology and Therapy, 2021, 11 : 1965 - 1998
  • [2] Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis
    Fahrbach, Kyle
    Sarri, Grammati
    Phillippo, David M.
    Neupane, Binod
    Martel, Samantha E.
    Kiri, Sandeep
    Reich, Kristian
    [J]. DERMATOLOGY AND THERAPY, 2021, 11 (06) : 1965 - 1998
  • [3] Efficacy and safety of apremilast monotherapy in moderate-to-severe plaque psoriasis: A systematic review and meta-analysis
    Aljefri, Yara E.
    Ghaddaf, Abdullah A.
    Alkhunani, Tala A.
    Alkhamisi, Taif A.
    Alahmadi, Rana A.
    Alamri, Awadh M.
    Alraddadi, Ali A.
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [4] Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
    Lucka, T. C.
    Pathirana, D.
    Sammain, A.
    Bachmann, F.
    Rosumeck, S.
    Erdmann, R.
    Schmitt, J.
    Orawa, H.
    Rzany, B.
    Nast, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (11) : 1331 - 1344
  • [5] The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis
    Sawyer, Laura
    Fotheringham, Iain
    Wright, Emily
    Yasmeen, Najeeda
    Gibbons, Carl
    Moller, Anders Holmen
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (06) : 557 - 568
  • [6] Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
    Singh, Siddharth
    Murad, M. Hassan
    Fumery, Mathurin
    Sedano, Rocio
    Jairath, Vipul
    Panaccione, Remo
    Sandborn, William J.
    Ma, Christopher
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 1002 - 1014
  • [7] Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response
    Sawyer, L. M.
    Cornic, L.
    Levin, L. A.
    Gibbons, C.
    Moller, A. H.
    Jemec, G. B.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (02) : 355 - 366
  • [8] Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis: A network meta-analysis
    Xu, Guomei
    Xia, Meng
    Jiang, Chenjie
    Yu, Ying
    Wang, Guomi
    Yuan, Jiaojiao
    Duan, Xingwu
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 139 (04) : 289 - 303
  • [9] Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year
    Yasmeen, Najeeda
    Sawyer, Laura M.
    Malottki, Kinga
    Levin, Lars-Ake
    Apol, Eydna Didriksen
    Jemec, Gregor B.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 204 - 218
  • [10] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia Attia
    Abdelrahman Ibrahim Abushouk
    Hussien Ahmed
    Mohamed Gadelkarim
    Ahmed Elgebaly
    Zeinab Hassan
    Mohamed M. Abdel-Daim
    Ahmed Negida
    [J]. Clinical Drug Investigation, 2017, 37 : 439 - 451